Search This Blog

Tuesday, May 7, 2019

Allergan raises FY19 adjusted EPS view to greater than $16.55, consensus $16.43

Prior view was greater than or equal to $16.36. Raises FY19 revenue view to $15.1B-$15.4B from $15B-$15.3B, consensus $15.2B.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.